Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: A retrospective 2-institution study

Annals of Surgery

Volumn 262, Issue 1, 2015, Pages 156-162

  Kelly, Kaitlyn J ^a   Yoon, Sam S ^a,b   Kuk, Deborah ^a   Qin, Li Xuan ^a   Dukleska, Katerina ^a   Chang, Kevin K ^b   Chen, Yen Lin ^b   Delaney, Thomas F ^b   Brennan, Murray F ^a   Singer, Samuel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Electron beam radiation therapy; Intensity modulated radiation therapy; Neoadjuvant radiation therapy; Proton beam radiation therapy; Retropertioneal sarcoma

Indexed keywords

BEVACIZUMAB; DOXORUBICIN; IFOSFAMIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURGERY; COMPARATIVE EFFECTIVENESS; DEDIFFERENTIATED LIPOSARCOMA; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; IMAGE GUIDED BIOPSY; INFERIOR CAVA VEIN; LEIOMYOSARCOMA; LENGTH OF STAY; LIPOSARCOMA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PELVIS TUMOR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE RADIOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTON RADIATION; RECURRENCE FREE SURVIVAL; RETROPERITONEAL SARCOMA; SURGICAL ANATOMY; TUMOR VOLUME; URINARY TRACT INFECTION; WELL DIFFERENTIATED LIPOSARCOMA; ADJUVANT THERAPY; AGED; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PELVIC NEOPLASMS; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDY; SARCOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PELVIC NEOPLASMS; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; TREATMENT OUTCOME;

EID: 84942293931     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001063     Document Type: Article

References (30)

1. Taylor BS, Barretina J, Maki RG, et al. Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer. 2011;11:541-557.
2. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235-2241.
3. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft-tissue sarcoma. J Clin Oncol. 1996;14:859-868.
4. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft-tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197-203.
5. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
6. Bartlett E, Yoon SS. Current treatment for the local control of retroperitoneal sarcomas. J Am Coll Surg. 2011;213:436-446.
7. Glenn J, Sindelar WF, Kinsella T, et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985;97: 316-325.
8. Tepper JE, Suit HD, Wood WC, et al. Radiation therapy of retroperitoneal soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 1984;10:825-830.
9. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128:402-410.
10. Yoon SS, Chen YL, Kirsch DG, et al. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol. 2010;17: 1515-1529.
11. McBride SM, Raut CP, Lapidus M, et al. Locoregional recurrence after preop-erative radiation therapy for retroperitoneal sarcoma: adverse impact of mul-tifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013;20:2140-2147.
12. Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate-or high-grade retroperitoneal soft-tissue sarcoma. Ann Surg Oncol. 2006;13: 508-517.
13. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000;47:157-163.
14. Alford S, Choong P, Chander S, et al. Outcomes of preoperative radiotherapy and resection of retroperitoneal sarcoma. ANZ J Surg. 2013;83:336-341.
15. National Cancer Institute. Common Terminology Criteria for Adverse Events. V e r s i o n 4. 0. Bethesda, MD: National Cancer Institute, National Institutes of Health; 2009. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE 4.03 2010-06-14 QuickReference 5x7.pdf. Accessed November 5, 2014.
16. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
18. Delaney TF, Kepka L, Goldberg SI, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007;67:1460-1469.
19. Herman K, Kusy T. Retroperitoneal sarcoma-the continued challenge for surgery and oncology. Surg Oncol. 1998;7:77-81.
20. Pawlik TM, Ahuja N, Herman JM. The role of radiation in retroperitoneal sarcomas: a surgical perspective. Curr Opin Oncol. 2007;19:359-366.
21. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;50:127-131.
22. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52:469-475.
23. Pezner RD, Liu A, Han C, et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperi-toneal sarcoma. Radiother Oncol. 2006;81:81-87.
24. Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006;107:371-379.
25. Bossi A, De Wever I, Van Limbergen E, et al. Intensity-modulated radiation therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys. 2007;67:164-170.
26. De Wever I, Laenen A, Van Limbergen E. Preoperative irradiation for retroperi-toneal liposarcoma: results of a pilot study. Acta Chir Belg. 2013;113:315-321.
27. National Institutes of Health. ClinicalTrials.gov. A Prospective Randomized Trial of Preoperative IMRT + Surgery Versus Surgery Alone for Primary Retroperitoneal Sarcoma 2005. Bethesda, MD: National Institutes of Health. Available at: http://clinicaltrials.gov/ct2/show/NCT00131898. Accessed August 6, 2013.
28. National Institutes of Health. ClinicalTrials.gov. Surgery With or Without Radiation Therapy in Treating Patients With Previously Untreated Nonmetastatic Retroperitoneal Soft-Tissue Sarcoma (STRASS) 2011. Bethesda, MD: National Institutes of Health. Available at: http://clinicaltrials.gov/show/NCT01344018. Accessed February 19, 2014.
29. Linehan DC, Lewis JJ, Leung D, et al. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18: 1637-1643.
30. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposar-coma. Ann Surg. 2003;238:358-370; discussion 370-371.